Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on April 3, 2008

Stroke. 2008
Published online before print April 3, 2008, doi: 10.1161/STROKEAHA.107.503433
A more recent version of this article appeared on June 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/6/1875    most recent
STROKEAHA.107.503433v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Todo, K.
Right arrow Articles by Hori, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Todo, K.
Right arrow Articles by Hori, M.
Related Collections
Right arrow Angiogenesis
Right arrow Other Stroke Treatment - Medical
Right arrow Other Vascular biology

Submitted on September 9, 2007
Revised on November 7, 2007
Accepted on November 8, 2007

Granulocyte-Macrophage Colony-Stimulating Factor Enhances Leptomeningeal Collateral Growth Induced by Common Carotid Artery Occlusion

Kenichi Todo MD*; Kazuo Kitagawa MD, PhD; Tsutomu Sasaki MD, PhD; Emi Omura-Matsuoka MD; Yasukazu Terasaki MD; Naoki Oyama MD; Yoshiki Yagita MD, PhD; and Masatsugu Hori MD, PhD

From the Division of Stroke, Department of Cardiovascular Medicine (K.T., T.S., E.O.-M., Y.T., N.O., M.H.), and Department of Neurology (K.K., Y.Y.), Osaka University Graduate School of Medicine, Japan.

* To whom correspondence should be addressed. E-mail: ktodo{at}medone.med.osaka-u.ac.jp.

Background and Purpose—Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been reported to accelerate collateral growth (arteriogenesis) at the circle of Willis in rat brain. However, the effect of GM-CSF on leptomeningeal collateral growth has not been established. We examined the effect of unilateral common carotid artery (CCA) occlusion and GM-CSF treatment on leptomeningeal collateral growth in mice.

Methods—Adult mice were subjected to unilateral CCA occlusion or sham surgery followed by an alternate-day regimen of GM-CSF (20 µg/kg) or saline injection. On day 7, latex perfusion was performed in 1 set of mice to visualize the leptomeningeal vessels, and the number of Mac-2+ monocytes/macrophages on the dorsal surface of the brain was counted. In another set of mice, on day 7, permanent ipsilateral middle cerebral artery (MCA) occlusion was performed, and infarct volume was measured.

Results—Leptomeningeal collateral growth was observed after CCA occlusion, and that was enhanced by GM-CSF treatment. An increase in the number of Mac-2+ cells on the surface of the brain occurred after CCA occlusion and was enhanced by GM-CSF treatment. Seven days after CCA occlusion, GM-CSF treatment decreased the infarct size attributable to subsequent MCA occlusion.

Conclusion—After CCA occlusion, GM-CSF treatment enhanced leptomeningeal collateral growth and decreased the infarct size after MCA occlusion in mice.


Key words: chronic ischemia • collateral perfusion • focal ischemia